Lowenthal Richard E sold SPRY
August 21, 2025 · Form 4 insider transaction
Lowenthal Richard E sold 50,000 shares of ARS Pharmaceuticals, Inc. at $14.49 per share, a transaction worth $724.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2025.; The weighted average sale price for the transaction reported was $14.4869 and the range of prices were between $14.31 and $14.61. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.; The Reporting Person is trustee of the trust.